ICM Co. Ltd.: Clinical Trials

4 trials sponsored by ICM Co. Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow ICM Co. Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis.
ICM-203 - Osteoarthritis, Knee
Phase 1 / Phase 2WithdrawnICM Co. Ltd.2026-11-152026-09-08
Multimodal Study of the Human Brain Epilepsy Tissue
Blood and tissue collection - Focal Drug-resistant Epilepsy
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris3002024-02-292026-07-16
A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo
ICM-203, Placebo - Osteoarthritis, Knee
Active not recruitingICM Co. Ltd.102023-03-162026-09-03
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
Clinical, biological and imaging assessment - Alzheimer's Disease, Parkinson's Disease
CompletedInstitut National de la Santé Et de la Recherche Médicale, France2202015-09-042021-12-03

Conditions studied

Osteoarthritis (2)  ·  Osteoarthritis, Knee (2)  ·  Alzheimer Disease (1)  ·  Parkinson Disease (1)

Interventions

Biological Products (1)  ·  Blood Specimen Collection (1)  ·  Tissue Banks (1)

Countries

France (2)  ·  Australia (1)  ·  Germany (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Alison Heald, MD (2)  ·  Vincent M. Navarro, MD, PHD (1)